Ep. 75: Catherine Wood: Tesla Leads These Tech Stocks Surging Higher As Innovations Accelerate
Investing With IBD
00:00
How CRISPR Gene Editing Can Help Cure Mutations
In 2003, it cost $2.7 billion to sequence the first whole human genome. Now some private companies can do it for just $500. CRISPR gene editing is already curing humans of sickle cell disease and beta thalassemia. Artificial intelligence might be able to help us understand when we're heading for stage one cancer.
Transcript
Play full episode
